Explore JAMA Network Open’s collection on clinical pharmacy and pharmacology, including topics in drug safety and development, pharmacogenetics, and more.
This cross-sectional study examines changes in revenues of manufacturers of drugs for treatment of hepatitis C and health care organizations after list price reductions.
This cohort study uses data from the Surveillance, Epidemiology, and End Results (SEER)–Medicare database to investigate the association between androgen deprivation therapy and diagnosis of Alzheimer disease or dementia among elderly men with prostate cancer.
This cohort study of Japanese participants with acute decompensated heart failure in the Kyoto Congestive Heart Failure study evaluates the association of mineralocorticoid receptor antagonist use with all-cause mortality and hospital readmission.
This population-based cohort study examines the rates of naloxone coprescription since implementation of state laws mandating coprescription for persons at risk for opioid overdose.
This cross-sectional analysis of the Disclosure UK database examines the concentration and patterns of drug company payments to health care organizations in the United Kingdom.
This cohort study compares overall and disease-specific survival associated with targeted vs nontargeted therapy in elderly patients with metastatic renal cell carcinoma who are enrolled in Medicare.
This cohort study evaluates adverse events in patients with hepatitis C virus who are receiving direct-acting antiviral medications.
This cross-sectional study uses 1000 Genomes Project data and US Veterans Health Administration demographic characteristics to project the number of veterans who carry an actionable pharmacogenetic variant and who have been prescribed 1 or more level A drugs that have well-established evidence of pharmacogenetic interactions.
This survey study investigates the availability of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 3 years after the implementation of a statewide standing order allowing pharmacies to dispense naloxone without a physician’s prescription.
This cohort study assesses the appropriateness of antibiotic prophylaxis prescriptions for infection prophylaxis before dental procedures using Truven, a US national integrated health claims database.
This economic evaluation study uses pharmaceutical insurance claims data to report the consistent rise in prices of commonly used prescription medicines in the United States.
This cross-sectional study compares the rate of opioid prescriptions by dentists dispensed from outpatient pharmacies and health care settings in the United States and England in 2016.
This cross-sectional analysis examines the characteristics and distribution of payments from pharmaceutical companies to researchers involved in the valsartan scandal in Japan.
This systematic review and meta-analysis investigates the association between the duration of adjuvant chemotherapy and survival among individuals diagnosed as having stage II and III colon cancer.
This cross-sectional study characterizes postapproval clinical trials sponsored by pharmaceutical companies of therapeutics approved by the US Food and Drug Administration (FDA) without postmarketing requirements or commitments.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: